Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.

• Urstadt Biddle Properties Inc. UBP shares surged 28.5% to $19.72.
• Eltek Ltd. ELTK rose 27.6% to $5.04 after the company reported better-than-expected Q1 financial results.
• SciPlay Corporation SCPL shares gained 26.4% to $19.66 after Light & Wonder announced a proposal to acquire the remaining public shares of the company.
• Urstadt Biddle Properties Inc. UBA climbed 19.4% to $20.23. Regency Centers announced plans to acquire Urstadt Biddle Properties in all-stock transaction valued at $1.4 billion.
• Hawkins, Inc. HWKN gained 16.5% to $50.15 following quarterly results.
• Dole plc DOLE surged 10.6% to $13.20 following upbeat quarterly earnings.
• Take-Two Interactive Software, Inc. TTWO rose 10.5% to $138.12 after the company reported fourth-quarter earnings results.
• Madison Square Garden Entertainment Corp. MSGE jumped 9.9% to $34.88 after posting a profit for the third quarter.
• Advanced Drainage Systems, Inc. WMS gained 9.9% to $97.47 following better-than-expected quarterly results.
• QuinStreet, Inc. QNST rose 9.6% to $8.41.
• Luminar Technologies, Inc. LAZR surged 9.4% to $7.16. Luminar Technologies Director, Chairperson, President & CEO Austin Russell acquired a total 1,475,685 shares an average price of $6.03.
• Bath & Body Works, Inc. BBWI surged 8.6% to $36.95 after the company reported better-than-expected first-quarter adjusted EPS results and issued guidance.
• DouYu International Holdings Limited DOYU rose 8% to $1.08 following first-quarter results.
• Netflix, Inc. NFLX rose 8% to $367.28 following a report suggesting the company said its ad-supported tier has nearly 5 million global monthly active users.
• DLocal Limited DLO shares gained 7.3% to $15.02 after the company reported better-than-expected Q1 results.
• Synopsys, Inc. SNPS gained 6.8% to $402.85 after the company reported better-than-expected Q2 financial results and issued FY23 guidance.
• Teva Pharmaceutical Industries Limited TEVA climbed 5.4% to $8.56. Evercore ISI Group upgraded Teva Pharmaceutical from In-Line to Outperform.

Read More: US Stocks Mixed; Jobless Claims Drop More than Projected